- Report
- January 2026
- 191 Pages
Global
From €3155EUR$3,545USD£2,708GBP
€3505EUR$3,939USD£3,009GBP
- Report
- January 2026
- 185 Pages
Global
From €3155EUR$3,545USD£2,708GBP
€3505EUR$3,939USD£3,009GBP
- Report
- January 2026
- 196 Pages
Global
From €3155EUR$3,545USD£2,708GBP
€3505EUR$3,939USD£3,009GBP
- Report
- January 2026
- 186 Pages
Global
From €3155EUR$3,545USD£2,708GBP
€3505EUR$3,939USD£3,009GBP
- Report
- January 2026
- 186 Pages
Global
From €3155EUR$3,545USD£2,708GBP
€3505EUR$3,939USD£3,009GBP
- Report
- December 2025
- 150 Pages
Global
From €5295EUR$5,950USD£4,545GBP
- Report
- September 2025
- 150 Pages
Global
From €5295EUR$5,950USD£4,545GBP
- Report
- January 2026
- 192 Pages
Global
From €3155EUR$3,545USD£2,708GBP
€3505EUR$3,939USD£3,009GBP
- Report
- May 2026
- 139 Pages
Global
From €2669EUR$2,999USD£2,291GBP
€3558EUR$3,999USD£3,055GBP
- Report
- April 2026
- 150 Pages
Global
From €2669EUR$2,999USD£2,291GBP
€3558EUR$3,999USD£3,055GBP
- Report
- April 2026
- 141 Pages
Global
From €2669EUR$2,999USD£2,291GBP
€3558EUR$3,999USD£3,055GBP
- Report
- April 2026
- 145 Pages
Global
From €2669EUR$2,999USD£2,291GBP
€3558EUR$3,999USD£3,055GBP
- Report
- April 2026
Global
From €4360EUR$4,900USD£3,743GBP
- Report
- January 2026
Global
From €4360EUR$4,900USD£3,743GBP
- Report
- September 2026
- 196 Pages
Global
From €5206EUR$5,850USD£4,469GBP
- Report
- September 2026
- 378 Pages
Global
From €5206EUR$5,850USD£4,469GBP
- Report
- September 2026
- 279 Pages
Global
From €5206EUR$5,850USD£4,469GBP
- Report
- September 2026
- 284 Pages
Global
From €5206EUR$5,850USD£4,469GBP
- Report
- September 2026
- 390 Pages
Global
From €5206EUR$5,850USD£4,469GBP
- Report
- September 2026
- 179 Pages
Global
From €5206EUR$5,850USD£4,469GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more